Irbesartan Hydrochlorothiazide BMS
irbesartan, hydrochlorothiazide
irbesartan/hydrochlorothiazide
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet,
please tell your doctor or pharmacist.
What Irbesartan Hydrochlorothiazide BMS is and what it is used for
Before you take Irbesartan Hydrochlorothiazide BMS
How to take Irbesartan Hydrochlorothiazide BMS
Possible side effects
How to store Irbesartan Hydrochlorothiazide BMS
Further information
Irbesartan Hydrochlorothiazide BMS is a combination of two active substances, irbesartan and hydrochlorothiazide.
Medicinal product no longer authorised
Irbesartan belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body that binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Irbesartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower.
Hydrochlorothiazide is one of a group of medicines (called thiazide diuretics) that causes increased
urine output and so causes a lowering of blood pressure.
The two active ingredients in Irbesartan Hydrochlorothiazide BMS work together to lower blood pressure further than if either was given alone.
if you are allergic (hypersensitive) to irbesartan or any of the other ingredients of Irbesartan Hydrochlorothiazide BMS
if you are allergic (hypersensitive) to hydrochlorothiazide or any other sulfonamide-derived medicines
if you are more than 3 months pregnant. (It is also better to avoid Irbesartan Hydrochlorothiazide BMS in early pregnancy – see pregnancy section)
if you have severe liver or kidney problems
if you have difficulty in producing urine
if your doctor determines that you have persistently high calcium or low potassium levels in your blood
Irbesartan Hydrochlorothiazide BMS should not be given to children and adolescents (under 18 years).
if you get excessive vomiting or diarrhoea
if you suffer from kidney problems or have a kidney transplant
if you suffer from heart problems
if you suffer from liver problems
if you suffer from diabetes
if you suffer from lupus erythematosus (also known as lupus or SLE)
if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
You must tell your doctor if you think you are (or might become) pregnant. Irbesartan Hydrochlorothiazide BMS is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
if you are on a low-salt diet
if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an
excessive effect of hydrochlorothiazide (contained in Irbesartan Hydrochlorothiazide BMS)
if you experience an increased sensitivity of the skin to the sun with symptoms of sunburn (such as redness, itching, swelling, blistering) occurring more quickly than normal
if you are going to have an operation (surgery) or be given anaesthetics
The hydrochlorothiazide contained in this medicine could produce a positive result in an anti-doping test.
Medicinal product no longer authorised
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Diuretic agents such as the hydrochlorothiazide contained in Irbesartan Hydrochlorothiazide BMS may have an effect on other medicines. Preparations containing lithium should not be taken with Irbesartan Hydrochlorothiazide BMS without close supervision by your doctor.
potassium supplements
salt substitutes containing potassium
potassium sparing medicines or other diuretics (water tablets)
some laxatives
medicines for the treatment of gout
therapeutic vitamin D supplements
medicines to control heart rhythm
medicines for diabetes (oral agents or insulins)
It is also important to tell your doctor if you are taking other medicines to reduce your blood pressure, steroids, medicines to treat cancer, pain killers or arthritis medicines.
Irbesartan Hydrochlorothiazide BMS can be taken with or without food.
Due to the hydrochlorothiazide contained in Irbesartan Hydrochlorothiazide BMS, if you drink alcohol while on treatment with this medicine, you may have an increased feeling of dizziness on standing up, specially when getting up from a sitting position.
You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Irbesartan Hydrochlorothiazide BMS before you become pregnant or as soon
as you know you are pregnant and will advise you to take another medicine instead of Irbesartan Hydrochlorothiazide BMS. Irbesartan Hydrochlorothiazide BMS is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Tell your doctor if you are breast-feeding or about to start breast-feeding. Irbesartan Hydrochlorothiazide BMS is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.
No studies on the effects on the ability to drive and use machines have been performed. Irbesartan Hydrochlorothiazide BMS is unlikely to affect your ability to drive or use machines. However, occasionally dizziness or weariness may occur during treatment of high blood pressure. If you
experience these, talk to your doctor before attempting to drive or use machines.
Medicinal product no longer authorised
Always take Irbesartan Hydrochlorothiazide BMS exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The usual dose of Irbesartan Hydrochlorothiazide BMS is one or two tablets a day. Irbesartan Hydrochlorothiazide BMS will usually be prescribed by your doctor when your previous treatment did not reduce your blood pressure enough. Your doctor will instruct you how to switch from the previous treatment to Irbesartan Hydrochlorothiazide BMS.
Irbesartan Hydrochlorothiazide BMS is for oral use. Swallow the tablets with a sufficient amount of fluid (e.g. one glass of water). You can take Irbesartan Hydrochlorothiazide BMS with or without food. Try to take your daily dose at about the same time each day. It is important that you continue to
take Irbesartan Hydrochlorothiazide BMS until your doctor tells you otherwise.
The maximal blood pressure lowering effect should be reached 6-8 weeks after beginning treatment.
If you accidentally take too many tablets, contact your doctor immediately.
Irbesartan Hydrochlorothiazide BMS should not be given to children under 18 years of age. If a child swallows some tablets, contact your doctor immediately.
If you accidentally miss a daily dose, just take the next dose as normal. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Irbesartan Hydrochlorothiazide BMS can cause side effects, although not everybody gets them.
Some of these effects may be serious and may require medical attention.
Rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/or tongue have been reported in patients taking irbesartan.
Side effects reported in clinical studies for patients treated with Irbesartan Hydrochlorothiazide BMS were:
nausea/vomiting
abnormal urination
fatigue
dizziness (including when getting up from a lying or sitting position)
blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase) or raised levels of substances that measure kidney function (blood urea nitrogen, creatinine).
Medicinal product no longer authorised
diarrhoea
low blood pressure
fainting
heart rate increased
flushing
swelling
sexual dysfunction (problems with sexual performance)
blood tests may show lowered levels of potassium and sodium in your blood.
The frequency of these effects is not known. These undesirable effects are: headache, ringing in the ears, cough, taste disturbance, indigestion, pain in joints and muscles, liver function abnormal and impaired kidney function, increased level of potassium in your blood and allergic reactions such as
rash, hives, swelling of the face, lips, mouth, tongue or throat.
As for any combination of two active substances, side effects associated with each individual component cannot be excluded.
In addition to the side effects listed above, chest pain has also been reported.
Loss of appetite; stomach irritation; stomach cramps; constipation; jaundice (yellowing of the skin and/or whites of the eyes); inflammation of the pancreas characterised by severe upper stomach pain, often with nausea and vomiting; sleep disorders; depression; blurred vision; lack of white blood cells, which can result in frequent infections, fever; decrease in the number of platelets (a blood cell
essential for the clotting of the blood), decreased number of red blood cells (anaemia) characterised by
tiredness, headaches, being short of breath when exercising, dizziness and looking pale; kidney disease; lung problems including pneumonia or build-up of fluid in the lungs; increased sensitivity of the skin to the sun; inflammation of blood vessels; a skin disease characterized by the peeling of the skin all over the body; cutaneous lupus erythematosus, which is identified by a rash that may appear
on the face, neck, and scalp; allergic reactions; weakness and muscle spasm; altered heart rate; reduced blood pressure after a change in body position; swelling of the salivary glands; high sugar levels in the blood; sugar in the urine; increases in some kinds of blood fat; high uric acid levels in the blood, which may cause gout.
It is known that side effects associated with hydrochlorothiazide may increase with higher doses of hydrochlorothiazide.
Keep out of the reach and sight of children.
Do not use Irbesartan Hydrochlorothiazide BMS after the expiry date which is stated on the carton and on the blister after EXP. The expiry date refers to the last day of that month.
Do not store above 30°C.
Store in the original package in order to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Medicinal product no longer authorised
The active substances are irbesartan and hydrochlorothiazide. Each tablet of Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, red and yellow ferric oxides (E172).
Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets. Unit dose blister packs of 56 x 1 tablet for delivery in hospitals are also available.
Not all pack sizes may be marketed.
BRISTOL-MYERS SQUIBB PHARMA EEIG
Uxbridge Business Park Sanderson Road
Uxbridge UB8 1DH - United Kingdom
SANOFI WINTHROP INDUSTRIE
1, rue de la Vierge Ambarès & Lagrave
F-33565 Carbon Blanc Cedex - France
SANOFI SYNTHELABO LIMITED
Edgefield Avenue - Fawdon
Newcastle Upon Tyne, Tyne & Wear NE3 3TT - United Kingdom
CHINOIN PRIVATE CO. LTD.
Lévai u.5.
2112 Veresegyház - Hungary
SANOFI WINTHROP INDUSTRIE
Medicinal product no longer authorised
30-36 Avenue Gustave Eiffel 37100 Tours - France
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
BRISTOL-MYERS SQUIBB BELGIUM S.A./N.V. Tél/Tel: + 32 2 352 76 11
BRISTOL-MYERS SQUIBB BELGIUM S.A./N.V. Tél/Tel: + 32 2 352 76 11
BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
Teл.: + 359 800 12 400
BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
Tel.: + 36 1 301 9700
BRISTOL-MYERS SQUIBB SPOL. S R.O. Tel: + 420 221 016 111
BRISTOL-MYERS SQUIBB S.R.L. Tel: + 39 06 50 39 61
BRISTOL-MYERS SQUIBB Tlf: + 45 45 93 05 06
BRISTOL-MYERS SQUIBB BV Tel: + 31 34 857 42 22
BRISTOL-MYERS SQUIBB GMBH & CO. KGAA Tel: + 49 89 121 42-0
BRISTOL-MYERS SQUIBB NORWAY LTD Tlf: + 47 67 55 53 50
Medicinal product no longer authorised
BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT. Tel: + 372 6827 400
BRISTOL-MYERS SQUIBB GESMBH Tel: + 43 1 60 14 30
BRISTOL-MYERS SQUIBB A.E.
Τηλ: + 30 210 6074300
BRISTOL-MYERS SQUIBB POLSKA SP. Z O.O. Tel.: + 48 22 5796666
BRISTOL-MYERS SQUIBB, S.A. Tel: + 34 91 456 53 00
BRISTOL-MYERS SQUIBB FARMACÊUTICA PORTUGUESA, S.A.
Tel: + 351 21 440 70 00
BRISTOL-MYERS SQUIBB SARL Tél: + 33 (0)810 410 500
BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT.
Tel: + 40 (0)21 272 16 00
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD BRISTOL-MYERS SQUIBB SPOL. S R.O.
Tel: + 353 (1 800) 749 749
Tel: + 386 1 236 47 00
VISTOR HF
Sími: + 354 535 7000
BRISTOL-MYERS SQUIBB SPOL. S R.O. Tel: + 421 2 59298411
BRISTOL-MYERS SQUIBB S.R.L. Tel: + 39 06 50 39 61
OY BRISTOL-MYERS SQUIBB (FINLAND) AB Puh/Tel: + 358 9 251 21 230
ΑΚΗΣ ΠΑΝΑΓΙΩΤΟΥ & ΥΙΟΣ Ε.Π.Ε. Τηλ: + 357 22 677038
BRISTOL-MYERS SQUIBB AB Tel: + 46 8 704 71 00
BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT. Tel: + 371 67 50 21 85
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD Tel: + 44 (0800) 731 1736
BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT. Tel: + 370 5 2790 762
Medicinal product no longer authorised